This is a working overview of reversed-phase HPLC, written for readers who want more than a one-paragraph summary but less than a textbook.
This page was last updated on 2026-03-04 and is reviewed periodically as new material appears.
The GIP receptor is expressed in pancreatic islets, adipose tissue, and the central nervous system, while GLP-1 receptors are found in pancreatic islets, the gastrointestinal tract, and the brain. Activation of both receptors can enhance glucose-dependent insulin secretion and reduce glucagon release. The relative contribution of each receptor to the overall pharmacological effect remains an area of ongoing investigation. Preclinical studies suggest that GIP receptor agonism may modulate appetite and energy balance, but the precise mechanisms in humans are not fully established.
In clinical research, tirzepatide has been studied in randomized controlled trials for glycemic control and body weight reduction. These trials typically measure changes in hemoglobin A1c and body weight over periods of several months. The drug is administered by subcutaneous injection, and its pharmacokinetic profile supports once-weekly dosing. Post-marketing surveillance continues to evaluate long-term outcomes and rare adverse events.
Tirzepatide is a synthetic peptide that acts as a dual agonist at the glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptors. The molecule contains 39 amino acids and features a C20 fatty diacid moiety attached via a linker, which promotes albumin binding and extends its circulating half-life. Its sequence incorporates non-natural amino acids and modifications that reduce susceptibility to degradation by dipeptidyl peptidase-4. This dual receptor activity distinguishes it from selective GLP-1 receptor agonists.
Long-term storage of lyophilised peptide powder is generally at minus twenty degrees Celsius or colder, with desiccant and protection from light. Short-term storage at two to eight degrees Celsius is common during active use. In solution, stability depends strongly on pH, concentration, and the presence of preservatives, and hydrolysis or aggregation can develop over weeks. Published stability data specific to this molecule are limited, so recommended conditions for research material are usually extrapolated from general peptide handling practice rather than from a dedicated study.
Bulk peptide material is normally characterised by reversed-phase high-performance liquid chromatography, which separates the target sequence from truncation products and other closely related impurities. Ultraviolet detection near 214 nanometres is common because the peptide backbone absorbs in that region. Mass spectrometry, usually electrospray ionisation coupled to a mass analyser, is used to confirm the molecular mass. Because the molecule carries a lipophilic side chain, gradient methods often need a relatively high organic modifier fraction to elute it within a practical retention window.
| Property | Value | Notes |
|---|---|---|
| Molecular class | Synthetic peptide | Dual GIP/GLP-1 receptor agonist |
| Amino acid count | 39 | Contains non-natural residues |
| Modification | C20 fatty diacid | Attached via linker; promotes albumin binding |
| Half-life | Approximately 5 days | Supports once-weekly dosing |
| Primary route | Subcutaneous injection | Not for intravenous use |
An extended fatty diacid moiety promotes binding to serum albumin, which slows renal clearance and extends the circulating half-life to roughly five days. That property supports once-weekly administration and largely explains the dosing interval described in clinical reports. Published data come mainly from large randomised programmes that evaluated glycaemic control and body weight over periods of many months. Long-term outcomes beyond those trial windows, including what happens after treatment stops, remain an active area of investigation.
Tirzepatide is a synthetic peptide built from thirty-nine amino acids. Its sequence is derived from native glucose-dependent insulinotropic polypeptide, or GIP, with several non-natural residues and a fatty diacid side chain attached through a linker. The molecule behaves as a dual agonist at two incretin receptors, GIP and GLP-1, instead of targeting a single receptor. This dual engagement separates it from earlier single-receptor incretin compounds and underpins most of its reported pharmacological activity.
Identity and purity are assessed by reversed-phase high-performance liquid chromatography, with mass confirmation by electrospray ionisation mass spectrometry. Peptide mapping after enzymatic digestion verifies the primary sequence. Size-exclusion chromatography quantifies aggregates, while circular dichroism provides a secondary-structure fingerprint. Bioanalytical quantification in plasma uses immunoassay or LC-MS/MS. Reported purity for research-grade lots is commonly 95 percent or higher, and residual water content is checked by Karl Fischer titration.
As a peptide, tirzepatide is handled as a lyophilised solid in research settings and as a preserved solution in finished products. Aqueous solubility is pH dependent and reaches a minimum near the isoelectric point, which lies close to pH 5.4. Stock solutions are typically prepared in neutral or slightly basic buffer to limit precipitation. The solid is hygroscopic and should be equilibrated to room temperature before opening so that condensation does not form on the powder surface.
Recommended storage for reference material is a freezer at approximately -20 degrees Celsius, protected from light and moisture. Commercial injectable presentations are stored refrigerated between 2 and 8 degrees Celsius and must not be frozen. Product labelling generally permits a limited period at controlled room temperature once dispensed, with the exact window depending on the presentation. Repeated temperature cycling is avoided because it can promote aggregation or deamidation of the peptide chain.
Clinical development proceeded through large phase 3 programmes in type 2 diabetes and in obesity or overweight with at least one weight-related comorbidity. Regulatory approvals followed in several jurisdictions for both indications. Weekly subcutaneous dosing reflects an elimination half-life of roughly five days. Open questions include the durability of metabolic effects after treatment stops, long-term cardiovascular and hepatic outcomes beyond completed trials, and whether the dual mechanism confers benefits independent of total receptor occupancy. Published literature continues to expand on these points. Substantial uncertainty remains about interindividual variability in response.
Tirzepatide is a synthetic linear peptide of 39 amino acids that acts as a dual agonist at the glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptors. Its sequence derives from native GIP but incorporates non-natural residues and a C20 fatty diacid moiety linked to a lysine side chain. The lipophilic chain promotes albumin binding, which slows renal clearance and extends circulation time. The unmodified peptide has a molecular formula of C225H348N48O68 and a molecular mass near 4,813 daltons.
Receptor activation by tirzepatide raises intracellular cyclic AMP through Gs-coupled signalling at both targets. At the GLP-1 receptor the downstream effect includes glucose-dependent insulin release, suppressed glucagon secretion, delayed gastric emptying, and reduced appetite signalling in the hypothalamus. GIP receptor engagement adds insulinotropic activity and appears to influence lipid handling in adipose tissue. Because both receptors are stimulated at the same time, the pharmacological profile differs from that of selective GLP-1 receptor agonists, and the relative contribution of each arm remains an area of active investigation.
Long-term storage of the solid generally relies on temperatures at or below minus twenty degrees Celsius, while short-term working stocks may be held refrigerated. Light exposure is limited because photodegradation can alter side chains over extended periods. Solutions prepared for analysis are less stable than the dry powder and are typically used within the same working day. Buffer choice matters, since some aqueous conditions favor deamidation or oxidation at specific residues. Stability data are usually generated under defined accelerated conditions and then extrapolated with stated assumptions.
Identity and purity are established with reversed-phase high-performance liquid chromatography, often paired with mass spectrometry for confirmation of the expected mass. Peptide mapping after enzymatic digestion verifies the primary sequence and detects substitutions. Size-exclusion chromatography quantifies aggregates and fragments, which are the impurities most often tracked for peptides of this size. Residual solvents, counterions, and water content fall under separate tests described in pharmacopeial chapters. Circular dichroism or nuclear magnetic resonance may be used in research settings to probe secondary structure, though such methods are less common in routine release testing.
Peptide active ingredients of this type are typically supplied as lyophilized powder because the dry form resists hydrolysis during transport. The material is hygroscopic, so vials are usually equilibrated to room temperature before opening to avoid condensation on the solid. Repeated freeze-thaw cycles can promote aggregation and are generally avoided by aliquoting stock into single-use portions. Personnel handling the powder work in controlled environments to limit inhalation of fine particles. Written procedures usually specify these steps rather than leaving them to individual judgment.
Otto Hahn – winner of the Enrico Fermi Award 1966 U.S Government, Department of Energy Otto Hahn on Nobelprize.org including the Nobel Lecture on 13 December 1946 From the Natural Transmutations of Uranium to Its Artificial Fission Award Ceremony Speech honoring Otto Hahn by Professor Arne Westgren, Stockholm. Otto Hahn and the Discovery of Nuclear Fission Archived 1 February 2014 at the Wayback Machine BR, 2008 Otto Hahn – Discoverer of Nuclear Fission Author: Dr. Anne Hardy (Pro-Physik, 2004) Otto Hahn (1879–1968) – The discovery of fission Visit Berlin, 2011. Otto Hahn – Discoverer of nuclear fission Otto Hahn – Founder of the Atomic Age Author: Dr Edmund Neubauer (Translation: Brigitte Hippmann) – Website of the Otto Hahn Gymnasium (OHG), 2007. Otto Hahn Award Otto Hahn Peace Medal in Gold Website of the United Nations Association of Germany (DGVN) in Berlin Otto Hahn Medal The history of the Hahn Meitner Institute (HMI) Helmholtz-Zentrum, Berlin 2011. Otto Hahn heads a delegation to Israel 1959 Website of the Max Planck Society, 2011. Biography Otto Hahn 1879–1968 Otto Hahn – A Life for Science, Humanity and Peace Archived 24 September 2015 at the Wayback Machine Hiroshima University Peace Lecture, held by Dietrich Hahn, 2 October 2013. Otto Hahn – Discoverer of nuclear fission, grandfather of the Atombomb GMX, Switzerland, 17 December 2013. Author: Marinus Brandl. Newspaper clippings about Otto Hahn in the 20th Century Press Archives of the ZBW
==== Nervous system ==== There are nerve cells, also known as neurons, present in the human body. They are branched out. These cells make up nervous tissue. A neuron consists of a cell body with a nucleus and cytoplasm, and cytoplasmic protrusions of an axon, and dendrites.
Docetaxel (DTX or DXL), sold under the brand name Taxotere among others, is a chemotherapy medication used to treat a number of types of cancer. This includes breast cancer, head and neck cancer, stomach cancer, prostate cancer and non-small-cell lung cancer. It may be used by itself or along with other chemotherapy medication. It is given by slow injection into a vein. Common side effects include hair loss, cytopenia (low blood cell counts), numbness, shortness of breath, nausea, vomiting, and muscle pains. Other severe side effects include allergic reactions and future cancers. Docetaxel-induced pneumotoxicity is also a well recognized adverse effect which has to be identified timely and treated after withholding the drug. Side effects are more common in people with liver problems. Use during pregnancy may harm the fetus. Docetaxel is in the taxane family of medications. It works by disrupting the normal function of microtubules and thereby stopping cell division. Docetaxel was patented in 1986 and approved for medical use in 1995. It is on the World Health Organization's List of Essential Medicines. Docetaxel is available as a generic medication.
=== Immune system === Factors that acutely affect leptin levels are also factors that influence other markers of inflammation, e.g., testosterone, sleep, emotional stress, caloric restriction, and body fat levels. While it is well-established that leptin is involved in the regulation of the inflammatory response, it has been further theorized that leptin's role as an inflammatory marker is to respond specifically to adipose-derived inflammatory cytokines. In terms of both structure and function, leptin resembles IL-6 and is a member of the cytokine superfamily. Circulating leptin seems to affect the HPA axis, suggesting a role for leptin in stress response. Elevated leptin concentrations are associated with elevated white blood cell counts in both men and women. Similar to what is observed in chronic inflammation, chronically elevated leptin levels are associated with obesity, overeating, and inflammation-related diseases, including hypertension, metabolic syndrome, and cardiovascular disease. While leptin is associated with body fat mass, the size of individual fat cells, and overeating, it is not affected by exercise (for comparison, IL-6 is released in response to muscular contractions). Thus, it is speculated that leptin responds specifically to adipose-derived inflammation. Leptin is a pro-angiogenic, pro-inflammatory, and mitogenic factor, the actions of which are reinforced through crosstalk with IL-1 family cytokines in cancer. High leptin levels have been also demonstrated in patients with COVID-19 pneumonia.
Nvidia revealed the GeForce GTX 1080, the world's first graphics card with DisplayPort 1.4 support on 6 May 2016. AMD followed with the Radeon RX 480 to support DisplayPort 1.3/1.4 on 29 June 2016. The Radeon RX 400 series will support DisplayPort 1.3 HBR and HDR10, dropping the DVI connector(s) in the reference board design. In February 2017, VESA and Qualcomm announced that DisplayPort Alt Mode video transport will be integrated into the Snapdragon 835 mobile chipset, which powers smartphones, VR/AR head-mounted displays, IP cameras, tablets and mobile PCs.
Sources: en.wikipedia.org
=== Dosage === Dosage for heparin reversal is 0.5mg to 1.0 mg protamine sulfate IV for every 100 IU of active heparin. Partial thromboplastin time (PTT) should be monitored at 5 to 15 minutes after dose then in 2–8 hours afterward.
In humans, its size is orders of magnitude greater than the number of proteins that are encoded by the genome, one percent of which encodes proteins that make, modify, localize or bind sugar chains, which are known as glycans." The outer surface of the cell is a sea of lipids with a fleet of sugar molecules, many of which are attached to proteins, fats or both, that interact with molecules outside the cell and are critical for the communication between cells and the stickiness of a cell. "Glycans are nature's biologic modifiers," says Jamey Marth, a Howard Hughes Medical Institute investigator at the University of California San Diego."Glycans generally don't turn physiologic processes on and off, rather they modify the behavior of the cell by responding to external stimuli."
Warden III, who largely planned the USAF attacks; within ten minutes of the attacks by 21 F117 aircraft on 38 targets, Iraq had lost its communications and radar; Lt-Col David Deptula; in the first wave were 4 Saudi Arabian Tornado aircraft, 4 Grumman A-6 Intruder and SEAD McDonnell Douglas F-4G Wild Weasel V aircraft, 5 Northrop Grumman EA-6B Prowler aircraft to provide electronic jamming of the Iraq airspace, and 21 McDonnell Douglas F/A-18 Hornet aircraft, each which dropped the AGM-88 HARM anti-radiation missile, to destroy the Iraq surface to air missile capability; Tomahawk missiles were fired from battleships in the Gulf and submarines in the Red Sea; the General Dynamics F-111 had around four thousand gallons of fuel; before advanced guidance systems for munitions, munitions would land according to the circular error probability, which was around a half-mile for a B-17 in World War II; the first laser-guided munitions were the Pave Tack system, which debuted on the F-111 in 1982, first deployed by F-111 aircraft from RAF Lakenheath; Duncan Lennox, editor of Jane's Strategic Weapon Systems; Theodore Postol; on one evening, twenty-eight MIM-104 Patriot missiles were launched against five ballistic missiles, which had broken up on re-entry to the earth's atmosphere - hitting any of these fractured ballistic missiles was almost impossible, due to the unforeseen changing aerodynamics; Lt-Col George Cusimano, deputy director of the USAF joint; the joint also deployed synthetic-aperture radar, to give a fuller view of ground forces, from the AN/APG-76 Doppler radar; the ground picture could be relayed to ground forces, such as in the Battle of Khafji on 29 January 1991; Royal Scots 1st Battalion, with GKN Warrior tracked armoured vehicles and Major John Potter; the experimental Ferranti TIALD laser-guided munitions were deployed by RAF Panavia Tornado aircraft to destroy Iraq hardened aircraft shelters in February 1991; 39th Regiment Royal Artillery deployed the M270 Multiple Launch Rocket System (MLRS); the land battle began on 24 February 1991, watched by the DOAE in Surrey; the land war did not last long, and on 26 February 1991 retreating Iraqi vehicles and tanks were systematically destroyed by AGM-114 Hellfire missiles, launched from undetected Boeing AH-64 Apache helicopters, resulting in total destruction; the USS Wisconsin battleship fired at Failaka Island, with surveillance provided by its AAI RQ-2 Pioneer drone. Narrated by Edward Hardwicke, directed by Chris Haws, produced by Richard Melman, made by InCA Productions 18 August The Healing Mind, about the field of psychoneuroimmunology; psychiatrist Janice Kielcolt-Glaser of Ohio State University College of Medicine; psychologist Barrie R. Cassileth; chemical pathologist Malcolm Carruthers takes a blood sample from a candidate, who has been driven around Brands Hatch at 115 mph; Theodore Melnechuk of the University of California; the body's immune system - the phagocytes destroy foreign bacteria, the natural killer cells destroy the body's own cells that are too damaged, and the lymphocyte T cells and B cells remember pathogens, with a corresponding antibody; experimental psychologist Robert Ader of the University of Rochester Medical Center conducted research on rats in 1975, with cyclophosphamide, which weakens the immune system, and immunologist Nicholas Cohen; prolonged secretion of endogenous opioid peptides may lower the immune function; neuroscientist David L. Felten of the University of Rochester; psychoimmunologist Nick Hall of the University of South Florida College of Medicine and an experiment with drama students, where lowering of T cells was found; Kathleen Dillon of Western New England College, where an experiment measured Ig A of candidates who watched types of television content, and found that Ig A temporarily increased with amusing content; psychiatrist Fawzy Fawzy of the University of California; psychiatrist Margaret Kemeny of UCLA. Narrated by Geoff Watts (of Radio 4's former Science Now series, produced by Geoff Deehan in the 1970s), directed by Yavar Abbas, produced by Geoff Deehan, made by Sandlin Productions 25 August Spacesuit, the spacesuits that astronauts wore during the Apollo missions to the Moon, and whether such spacesuits would be advanced enough to be worn for future missions to Mars; by 2020, NASA expected to have landed on Mars; at sea-level, air pressure is 14 PSI; ILC Dover in Newark, Delaware has made all NASA spacesuits since the late 1960s; medical research at the Ames Research Center; Joe Kosmo, head of NASA spacesuit design; the invention of the defecation-mitten by Matthew Radnofsky; Bruce Webbon of the Ames Research Centre; the Johnson Space Center also worked on suit design. Directed by Patrick Uden, made by Uden Associates 1 September The Falls, about the Niagara Falls. Produced by Clare Odgers, made by the National Film Board of Canada and Primitive Features 8 September Re-inventing Japan, looking at Japan's success in applied science, contrasted with less success in pure science and whether Japan could enhance its pure science industry enough, which has connections with a country's own cultural values and outlook, and how Britain has excelled in pure science, but how much that university funding cuts could erode Britain's prowess in pure science; Japan few Nobel prizes, but excelled at applied science and exploiting others' research by reverse engineering; Canon had £6bn of sales, of which 40% were photocopiers, such as the L5; Hajime Mitarai, research director of Canon, and how Canon had eight product divisions, with their own engineering staff in each division, with process physicists and inorganic chemists; with Western science innovations, it often came from a set of individuals, whereas Japan's innovation culture revolved around much intense group cooperation, not individuals; Japan had only won five Nobel prizes since the 1950s - the US had won 135; a youthful Matt Ridley of The Economist; Fujitsu was the world's second-largest manufacturer of computers, and had bought ICL (which had been Ferranti) in 1990, and sold £10bn a year; Naoki Yokoyama and Takahiko Misugi of Fujitsu; Japan could not rely on other countries research anymore, and had to conduct more in-house research; Japan's culture was not greatly known for originality or taking risks, or being surprised; pathologist Sir Anthony Epstein and how Japan greatly revered tradition, and conformity, possibly viewing anyone who didn't likewise confirm as troublesome; electrical engineer Hiroya Fujisaki, of Tokyo University and known for the Fujisaki model, and that he thought that Japan's culture had historically eroded originality; the national research organisation Riken was formed in 1917, and made great progress, with a large cyclotron, and visited by Einstein in December 1922, but the US was suspicious after the war, and destroyed Riken's cyclotron; Minoru Oda, head of Riken from 1988 to 1993; the US distrusted Japan, and preferred Japan to work on mainly applied science; physicist Akira Tonomura at the Hitachi Advanced Laboratory, which had the world's largest electron microscope; Shojiro Asai of Hitachi; the Canon Advanced Research Laboratory; the Tsukuba Science City and the University of Tsukuba, built by the Japanese government for £6bn, and home of the Japanese ERATO science innovation agency; Genya Chiba, director of ERATO; Michio Nagai, former minister of education in the mid-1970s. Directed by Bob Bee, produced by Michael Wills (later Labour MP from 1997 to 2010 for North Swindon), and made by Juniper Productions 13 September Theme Park Heaven, Walt Disney; Sylvère Lotringer of Columbia University; Arrow Dynamics of California, with Dal Freeman Ron Toomer; David Lewis; Cedar Point, built by Custom Coasters International of Cincinnati; Eric Westin of Walt Disney Imagineering, and the Big Thunder Mountain Railroad ride; Marc Davis, who drew Tinkerbell in Peter Pan, and who worked on the Pirates of the Caribbean ride, which opened in 1967; Larry Lester and David Codiga of Universal Studios, and their earthquake Studio Tour and Backdraft rides; Dreamland in 1912; psychologist Timothy Leary; Douglas Trumbull and the Back to the Future: The Ride and Luxor Las Vegas; Stan Kinsey of SimEx-Iwerks; Michael Ryder and Thom Dickeson of Evans & Sutherland, and texture mapping onto polygons, a main feature of transportation simulations; Bob Stone of the Advanced Robotics Research Centre at the University of Salford. Narrated by Richard O'Brien, produced by Jerome Kuehl, directed by Graham Moore, made with WGBH and Open Media 22 September The Professor's New Clothes, a re-broadcast of an Australian documentary about Professor Vishwa Jit Gupta of Panjab University and his fraudulent work about paleontology of the Himalayas. Directed by Stephen Ramsey, produced by Janet Bell, and made by Film Australia 29 September The Gambler's Guide to Winning, the ways of deploying mathematical techniques to win in gambling, with probability theory methods developed by Prof Edward O. Thorp of University of California, Irvine; the disastrous 1967 Grand National, where nearly all the horses fell at the 23rd fence; Frank Honywill George of Brunel University; Ralph Abraham of University of California, Santa Cruz; Peter A. Griffin of California State University, Sacramento; the gambler's fallacy; J. Doyne Farmer of the Santa Fe Institute. Narrated by Andrew Burt, directed by Julian Nott (son of the Conservative former defence secretary Sir John Nott, who later composed the music for Wallace and Gromit films such as The Wrong Trousers), produced by Jenny Barraclough, made by Peninsula Films 6 October Superpowers?, with Ray Hyman, about the international group of sceptics Committee for Skeptical Inquiry, who dispute topics such as UFOs, made by Open Media 13 October The Lean Burn Machine, about the development of catalytic converters for automotive engines, and how they cause more fuel to be burned than before, and the British engineer Geoffrey West who has produced an alternative, but faced restrictions from EC (EU) legislation; Europe introduced pollution legislation in July 1992; California had the worst vehicle pollution in the US, notably LA; the Clean Air Act; Rob Searles of Johnson Matthey; German environment minister Bernd Schmidbauer - Germany had over two-thirds of European car exports to the US; French physicist Hubert Curien, Minister of Higher Education, Research and Innovation from 1988 to 1993; chemistry graduate Margaret Thatcher being interviewed on 2 March 1989 on the BBC, and lean-burn engines; Bernard Bertrand, head of engine development of Peugeot; Shillington of BL; the new EC legislation in 1992 would outlaw lean-burn powered cars; Dutch automotive writer Gerard Sauer. Narrated by Nick Ross, directed by Nick Abson and Simon Broom, produced by Michael Blakstad (Editor from 1974 of Tomorrow's World), made by Workhouse 20 October The Elements, the poet Roger McGough narrates poetry for each element and how the Periodic Table came to be formed; 5% of the Earth's crust is iron; xenon is found in strobe lights; argon is in domestic incandescent light bulbs; the light bulb filament is tungsten, but reserves of tungsten are low. Directed by Ian Duncan, produced by David Dugan, made by Windfall Films (part of Argonon). Shown on 25 November 1992 on The Nature of Things in Canada 27 October The Strange Case of Crop Circles, an update to the documentary made in 1990, looking at why the 250 crop circles that appeared in the summer, that around 50% of the circles appeared in Wiltshire; the phenomenon took off after a circle near Westbury was pictured in a local newspaper in 1980; Tim Carson charged £1 per visitor to a circle in 1990, and 7,000 visited the Eastfield Pictogram at Alton Barnes, near Milk Hill; Steve Woolgar; Sir Francis Graham-Smith of the Royal Society, who dismissed those people interested in crop circles as mixed company who talked a lot of rubbish and it was a profit-less business to get involved with people who were completely hooked on the unknown; Serena Roney-Dougal; a youthful-looking Matt Ridley of The Economist said that since episodes with nuclear power in the 1970s, people had questioned evidence that scientists had told them; physicist Terence Meaden, who founded TORRO; Yoshi-Hiko Ohtsuki of Waseda University, who researched ball lightning. Narrated by Gavin Weightman, directed by Jill Freeman, and produced by her husband Michael Wills, made by Juniper Productions 3 November Human Waste, new ways of treating excrement such as dry compost toilets, oxidation pools and greenhouses. Directed by Kate Woods (Australian), made by John Blake Associates
=== Studies in vitro === Epitalon appears to induce telomere elongation via increased telomerase activity in human somatic cells in vitro, based on a study in human fibroblast cell cultures. Elongation of telomeres by epitalon was sufficient to surpass the Hayflick limit in a cell culture of human fetal fibroblast cells, extending their proliferative potential from termination at the 34th passage in the control cell population to beyond the 44th passage in the treated cell population, while increasing the lengths of their telomeres to levels comparable to those of cells in the original culture. Epitalon induces decondensation of heterochromatin near the centromeres in cultured lymphocytes originating from samples taken from humans of ages 76 to 80 years. Epitalon appears to inhibit the synthesis of the MMP9 protein in vitro in aging skin fibroblasts.
== Clinical significance == An abnormal widening of the linea alba and the abdomanal wall generally is known as diastasis recti. A median incision through the linea alba is a common surgical approach for abdominal surgery. This is because it consists of mostly connective tissue, and does not contain any primary nerves or blood vessels. The linea alba is narrower below the belly button and is hard to close (sew together), so it a common site of hernias following surgery. In C-sections, the two rectus abdominis muscles must be separated in order to access the uterus underneath; in most C/S techniques, these are typically manually pulled apart, and thus "blunt dissection" (tearing) through the linea alba occurs. In Pfannenstiel-Kerr method sharp dissection (cutting with a scalpel) is used.
Sources: en.wikipedia.org
==== Laser-assisted nonpenetrating deep sclerectomy ==== The most common surgical approach currently used for the treatment of glaucoma is trabeculectomy, in which the sclera is punctured to alleviate intraocular pressure. Nonpenetrating deep sclerectomy (NPDS) surgery is a similar, but modified, procedure, in which instead of puncturing the scleral bed and trabecular meshwork under a scleral flap, a second deep scleral flap is created, excised, with further procedures of deroofing the Schlemm's canal, upon which, percolation of liquid from the inner eye is achieved and thus alleviating intraocular pressure, without penetrating the eye. NPDS is demonstrated to have significantly fewer side effects than trabeculectomy. However, NPDS is performed manually and requires higher level of skills that may be assisted with instruments. In order to prevent wound adhesion after deep scleral excision and to maintain good filtering results, NPDS as with other non-penetrating procedures is sometimes performed with a variety of biocompatible spacers or devices, such as the Aquaflow collagen wick, ologen Collagen Matrix, or Xenoplast glaucoma implant. Laser-assisted NPDS is performed with the use of a CO2 laser system. The laser-based system is self-terminating once the required scleral thickness and adequate drainage of the intraocular fluid have been achieved.
==== Nutritional supplements ==== OI is a genetic disorder and is not caused by insufficient intake of any vitamin or mineral; supplementation cannot cure OI. Nevertheless, people with OI tend to be severely deficient in vitamin D at much higher rates than the general population, and the cause of this is not well understood. The severity of the deficiency and the likelihood of its occurrence is thought to be related to severity of OI. Vitamin D supplementation may be recommended, at least until levels of 25(OH)D3 in a patient's blood return to normal. Vitamin D deficiency is also a concern as it may decrease the benefit of bisphosphanates.
== Gameplay == Sven Co-op is a first-person shooter based on Half-Life, using its GoldSrc game engine. The modification enables a server to be hosted, so many players can cooperate (along with any allied non-player characters) to complete levels against creatures and other enemies that are controlled by the computer. The modification was initially based around the levels from Half-Life, but since have expanded to include the other Half-Life games and user-made levels. Multiple levels may be connected to make a longer campaign by the level designer. The game can also be played in single-player mode, taking advantage of improvements over the original Half-Life that were made by the modifications, particularly the artificial intelligence used by non-player characters.
A potentially controversial method of producing biopharmaceuticals involves transgenic organisms, particularly plants and animals that have been genetically modified to produce drugs. This production is a significant risk for its investor due to production failure or scrutiny from regulatory bodies based on perceived risks and ethical issues. Biopharmaceutical crops also represent a risk of cross-contamination with non-engineered crops, or crops engineered for non-medical purposes. One potential approach to this technology is the creation of a transgenic mammal that can produce the biopharmaceutical in its milk, blood, or urine. Once an animal is produced, typically using the pronuclear microinjection method, it becomes efficacious to use cloning technology to create additional offspring that carry the favorable modified genome. The first such drug manufactured from the milk of a genetically modified goat was ATryn, but marketing permission was blocked by the European Medicines Agency in February 2006. This decision was reversed in June 2006 and approval was given August 2006.
Reumer, de Vos & Wibowo (2026) interpret Hemimachairodus zwierzyckii from the Pleistocene strata from Sangiran (Java, Indonesia) as a junior synonym of Homotherium latidens. Pérez et al. (2026) identify fossil material of lynxes from Serpenteko Leze de Mezkiritz pit (Navarre, Spain) as including remains of both the Iberian lynx and the Eurasian lynx, providing possible evidence of overlap of ranges of both species in northern Iberia around the Pleistocene–Holocene transition. Witt, Hotchner & Meachen (2026) report that postcranial remains of Miracinonyx trumani and cougars can be reliably differentiated on the basis of their postcranial remains, and identify fossils of M. trumani from new localities in United States and Mexico. Cassatt-Johnstone et al. (2026) determine Miracinonyx trumani to be the sister taxon of the cougar on the basis of data from high-coverage paleogenomes, identify three purported Pleistocene cougar individuals from Yukon (Canada) as individuals of M. trumani instead (extending known geographical range of the species), and report evidence of dietary differences between specimens of M. trumani from Yukon and Wyoming (United States). Lyubimov et al. (2026) report the discovery of fossil material of Acinonyx pardinensis from the Muhkai 2 site (Dagestan, Russia), representing the first record of the species in the northeastern Caucasus.
Sources: en.wikipedia.org
It activates both GIP and GLP-1 receptors. This dual action differentiates it from selective GLP-1 agonists.
It is given as a subcutaneous injection. Its long half-life supports weekly dosing.
No, it is synthetic. It contains non-natural amino acids and a fatty acid modification.
It separates molecules by hydrophobicity, which is effective for distinguishing an intact peptide from truncated or chemically modified forms. A C18 column with an acidic water-organic mobile phase is a standard configuration.